Skip to content
SEARCH icon
  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Trade Alerts
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
      Biotech

      AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

      March 9, 2025
      BioLab Holdings, Inc. Announces Partnership with Real Collagen GmbH
      Biotech

      BioLab Holdings, Inc. Announces Partnership with Real Collagen GmbH

      March 8, 2025
      Global Biosensors Market to Show Positive Growth at a CAGR of ~8% by 2032 | DelveInsight
      Biotech

      Global Biosensors Market to Show Positive Growth at a CAGR of ~8% by 2032 | DelveInsight

      March 7, 2025
      FDA Roundup: March 4, 2025
      Biotech

      FDA Roundup: March 4, 2025

      March 6, 2025
      Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight
      Biotech

      Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight

      March 5, 2025
      CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
      Biotech

      CARsgen’s Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA

      March 4, 2025
      New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms
      Biotech

      New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms

      March 3, 2025
      POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
      Biotech

      POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

      March 2, 2025
      FDA Roundup: February 28, 2025
      Biotech

      FDA Roundup: February 28, 2025

      March 1, 2025
      Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe
      Biotech

      Brainomix Partners with Medtronic to Enhance Stroke Care Across Western Europe

      February 28, 2025
      « 1 … 23 24 25 26 27 … 29 »

       

      LATEST NEWS

      • Investing News HSBC Q3 Earnings Overview
      • Investing News Novartis Eyes Major M&A Deals
      • Investing News Wayfair’s Q3 2025 Earnings Overview
      • Investing News UPS Q3 2025 Earnings Report Analysis

      Trending Stock Alerts

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Trending Stock Alerts.

      I want e-mail alerts, updates, and offers and agree to the Trending Stock Alerts privacy policy.

      Market Jar Media Inc. © 2025